Finanzwire Finanzwire
Basculer en Français
10988 Companies
240700 Keywords
169376 Articles
129553 Press releases
Headlines Articles Press releases Tanvex BioPharma USA, Inc. Remove
  1. Home
  2. Companies
  3. Tanvex BioPharma USA, Inc.
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 08/19/2024 at 13:05, 2 years ago

    Tanvex BioPharma USA, Inc. Achieves Dual U.S. Regulatory Milestones: FDA Approves Nypozi(TM) and FDA Accepts Biosimilar Biologics License Application for TX-05

    FDA Approval Cancer Treatment Healthcare Innovation Biosimilar Neutropenia
  • PRESS RELEASE

    published on 08/19/2024 at 13:00, 2 years ago

    Tanvex BioPharma USA, Inc. Achieves Dual U.S. Regulatory Milestones: FDA Approves Nypozi(TM) and FDA Accepts Biosimilar Biologics License Application for TX-05

    Tanvex BioPharma USA, Inc. receives FDA approval for NYPOZI™ biosimilar and FDA BLA acceptance for TX-05, showcasing expertise in biologics development and manufacturing
    FDA Approval Biologics Tanvex BioPharma NYPOZI TX-05
    Logo of Tanvex BioPharma USA, Inc.
  • PRESS RELEASE

    published on 10/16/2023 at 14:00, 2 years 10 months ago

    Tanvex CDMO Launch Empowers Advancements in Novel Biologics and Biosimilars

    Logo of Tanvex BioPharma USA, Inc.
Accesswire
  • Published on 09/15/2026 at 15:00, 3 minutes ago

    Jaguar Health, Inc. Announces Reverse Stock Split

  • Published on 09/15/2026 at 14:31, 32 minutes ago

    First Breach Secures Federal Explosives License for Attritible Drone Manufacturing

  • Published on 09/15/2026 at 14:30, 33 minutes ago

    Predictiv AI Completes End-to-End Logistics Platform for Prompt Xpress's National Delivery Network

  • Published on 09/15/2026 at 14:05, 58 minutes ago

    NuRAN Wireless Announces US ATM Offering

  • Published on 09/15/2026 at 14:00, 1 hour 3 minutes ago

    EQ Works and Pattison Media Announce Strategic Partnership to Power Next-Generation Radio Audience Intelligence

View all ACCESSWIRE
EQS Group
  • Published on 09/15/2026 at 14:46, 17 minutes ago

    Bio-Gate AG: First Comparative Clinical Data on HyProtect™ in Trauma Care—Significantly Higher Treatment Success Rate for Infected, Non-Healed Femur Fractures

  • Published on 09/15/2026 at 14:45, 18 minutes ago

    Momentus Technologies Launches MomentusMAX, an AI Platform Built for Venues, and Brings MAX for Sales to General Availability

  • Published on 09/15/2026 at 14:10, 53 minutes ago

    Carbon credits move into the Boardroom as Nine in Ten Buyers Report Real Business Gains

  • Published on 09/15/2026 at 14:05, 58 minutes ago

    Kibar Americas Celebrates Grand Opening of Fairmont Aluminum Manufacturing Facility

  • Published on 09/15/2026 at 14:05, 58 minutes ago

    DeepL Voice now preserves your voice in real-time multilingual conversations

View all EQS
Les Echos
  • Published on 09/15/2026 at 07:00, 8 hours 3 minutes ago

    AXA announces its 2027-2029 strategy and financial targets

  • Published on 09/14/2026 at 18:21, 20 hours 42 minutes ago

    Reporting on share buyback transactions carried out between September 7 and September 10, 2026

  • Published on 09/14/2026 at 17:45, 21 hours 18 minutes ago

    Weekly share buyback

  • Published on 09/14/2026 at 17:35, 21 hours 28 minutes ago

    Disclosure of transactions in own shares from September 7 to September 11, 2026

  • Published on 09/14/2026 at 16:15, 22 hours 48 minutes ago

    Statement about the number of shares composing the share capital and the number of voting rights as of August 31, 2026

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy